Irritable colon syndrome treated with an antispasmodic drug.
It was concluded that the trial had demonstrated therapeutic effects from dicyclomine in comparison with the placebo. Thus, the differences recorded, some of which were statistically significant, were all in favour of the active drug, despite the fact that a carry-over effect was apparent in the patients treated with dicyclomine first.
D002986:Clinical Trials as Topic; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D003672:Defecation; D003967:Diarrhea; D004025:Dicyclomine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005414:Flatulence; D006801:Humans; D008297:Male; D010146:Pain; D013312:Stress, Physiological
D003509:Cyclohexanecarboxylic Acids; D004025:Dicyclomine